Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prediction of psoriatic arthritis risk: watch for symptoms.

The Lancet. Rheumatology·2026

Same author

Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Same author

Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials: a GRAPPA-OMERACT systematic review and network meta-analysis.

Annals of the rheumatic diseases·2026

Same author

Addressing Cardiovascular Risk in People With Psoriatic Disease Using a Care Coordinator Model: A Qualitative Analysis of a Pilot Study.

Journal of psoriasis and psoriatic arthritis·2026

Same author

Artificial intelligence versus experts: Navigating challenging cases in psoriatic disease.

The Journal of investigative dermatology·2026

Same author

Thresholds for efficacy outcomes in psoriatic arthritis vary according to baseline disease activity but not according to prior tumour necrosis factor inhibitor treatment.

Annals of the rheumatic diseases·2026

Same journal

Sensory nerves protect against tendon degeneration.

Nature reviews. Rheumatology·2026

Same journal

Publisher Correction: TLR7 in systemic lupus erythematosus: genetics and emerging therapies.

Nature reviews. Rheumatology·2026

Same journal

TLR7 in systemic lupus erythematosus: genetics and emerging therapies.

Nature reviews. Rheumatology·2026

Same journal

Lung disease in rheumatoid arthritis.

Nature reviews. Rheumatology·2026

Same journal

Diagnostic, prognostic and therapeutic biomarkers in rheumatoid arthritis.

Nature reviews. Rheumatology·2026

Same journal

Progress made and the road ahead for cancer screening in myositis.

Nature reviews. Rheumatology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Oct 17, 2025

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Does psoriasis treatment affect PsA development?

Joseph F Merola¹, Alexis Ogdie²

¹Department of Dermatology and Department of Medicine, Division of Rheumatology and Immunology, Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA. jfmerola@bwh.harvard.edu.

Nature Reviews. Rheumatology

|October 12, 2021

Summary

No abstract available in PubMed .

More Related Videos

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

Related Experiment Videos

Last Updated: Oct 17, 2025

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014